GeneDx Holdings Corp. WGS
Set alert
At close · Nov 2
After hours · Nov 2, 5:00 PM ET
- YTD
- -50.72%
- 1 year
- -53.19%
- Open
- 69.15
- Prev close
- 69.06
- Mkt cap
- 1.91B
- Vol
- 1.15M
- Avg vol
- 764.45K
- EPS
- -3.63
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 63.61
- High
- 69.53
- Forward P/E
- 53.47
- Beta
- 1.99
- Short ratio
- 7.23
- Inst. own
- 108.66%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 9, 2026
- 50-d avg
- 79.04
- 200-d avg
- 71.93
- 1y target
- 93.50
5D chart
Signals (139)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 3:40 PM | 6 hours ago |
| SMA: Bullish | Nov 2, 3:35 PM | 6 hours ago |
| SMA: Bearish | Nov 2, 3:25 PM | 6 hours ago |
| SMA: Bullish | Nov 2, 2:55 PM | 7 hours ago |
| SMA: Bearish | Nov 2, 2:30 PM | 7 hours ago |
| SMA: Bullish | Nov 2, 2:20 PM | 7 hours ago |
| SMA: Bearish | Nov 2, 2:15 PM | 7 hours ago |
| SMA: Bullish | Nov 2, 2:10 PM | 7 hours ago |
| MACD: Buy Signal | Nov 2, 2:10 PM | 7 hours ago |
| MACD: Sell Signal | Nov 2, 1:40 PM | 8 hours ago |
| MACD: Buy Signal | Nov 2, 1:35 PM | 8 hours ago |
| MACD: Sell Signal | Nov 2, 1:30 PM | 8 hours ago |
| SMA: Bearish | Nov 2, 1:15 PM | 8 hours ago |
| SMA: Bullish | Nov 2, 1:10 PM | 8 hours ago |
| SMA: Bearish | Nov 2, 1:05 PM | 9 hours ago |
| MACD: Buy Signal | Nov 2, 1:05 PM | 9 hours ago |
| SMA: Bullish | Nov 2, 1:00 PM | 9 hours ago |
| RSI: Oversold | Nov 2, 12:40 PM | 9 hours ago |
| RSI: Oversold | Nov 2, 12:30 PM | 9 hours ago |
| SMA: Bearish | Nov 2, 12:10 PM | 9 hours ago |
| SMA: Bullish | Nov 2, 12:05 PM | 10 hours ago |
| SMA: Bearish | Nov 2, 10:30 AM | 11 hours ago |
| SMA: Bearish | Nov 2, 10:30 AM | 11 hours ago |
| MACD: Sell Signal | Nov 2, 10:30 AM | 11 hours ago |
| MACD: Buy Signal | Nov 2, 10:25 AM | 11 hours ago |
| SMA: Bullish | Nov 2, 10:15 AM | 11 hours ago |
| SMA: Bullish | Nov 2, 10:15 AM | 11 hours ago |
| SMA: Bearish | Nov 2, 9:40 AM | 12 hours ago |
| MACD: Sell Signal | Nov 2, 9:40 AM | 12 hours ago |
| SMA: Bearish | Nov 2, 9:30 AM | 12 hours ago |
| SMA: Bullish | Oct 30, 3:05 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:50 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:25 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:00 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 2:00 PM | 3 days ago |
| SMA: Bearish | Oct 30, 11:35 AM | 3 days ago |
| MACD: Sell Signal | Oct 30, 11:35 AM | 3 days ago |
| SMA: Bullish | Oct 30, 11:30 AM | 3 days ago |
| SMA: Bearish | Oct 30, 11:25 AM | 3 days ago |
| SMA: Bearish | Oct 30, 11:25 AM | 3 days ago |
| SMA: Bullish | Oct 30, 11:05 AM | 3 days ago |
| SMA: Bullish | Oct 30, 11:05 AM | 3 days ago |
| SMA: Bearish | Oct 30, 11:00 AM | 3 days ago |
| SMA: Bearish | Oct 30, 11:00 AM | 3 days ago |
| SMA: Bullish | Oct 30, 10:50 AM | 3 days ago |
| MACD: Buy Signal | Oct 30, 10:50 AM | 3 days ago |
| SMA: Bullish | Oct 30, 10:45 AM | 3 days ago |
| SMA: Bearish | Oct 30, 10:40 AM | 3 days ago |
| SMA: Bearish | Oct 30, 10:40 AM | 3 days ago |
| SMA: Bullish | Oct 30, 10:35 AM | 3 days ago |
| SMA: Bullish | Oct 30, 10:35 AM | 3 days ago |
| SMA: Bearish | Oct 30, 10:30 AM | 3 days ago |
| SMA: Bearish | Oct 30, 10:30 AM | 3 days ago |
| SMA: Bullish | Oct 30, 10:15 AM | 3 days ago |
| SMA: Bullish | Oct 30, 10:15 AM | 3 days ago |
| SMA: Bearish | Oct 30, 10:00 AM | 3 days ago |
| SMA: Bullish | Oct 30, 9:55 AM | 3 days ago |
| SMA: Bearish | Oct 30, 9:40 AM | 3 days ago |
| SMA: Bearish | Oct 30, 9:40 AM | 3 days ago |
| MACD: Sell Signal | Oct 30, 9:40 AM | 3 days ago |
| SMA: Bullish | Oct 30, 9:35 AM | 3 days ago |
| SMA: Bullish | Oct 30, 9:35 AM | 3 days ago |
| MACD: Buy Signal | Oct 30, 9:35 AM | 3 days ago |
| SMA: Bearish | Oct 30, 9:30 AM | 3 days ago |
| SMA: Bearish | Oct 30, 9:30 AM | 3 days ago |
| MACD: Sell Signal | Oct 30, 9:30 AM | 3 days ago |
| RSI: Overbought | Oct 29, 3:50 PM | 4 days ago |
| MACD: Buy Signal | Oct 29, 3:35 PM | 4 days ago |
| SMA: Bullish | Oct 29, 3:15 PM | 4 days ago |
| SMA: Bearish | Oct 29, 3:10 PM | 4 days ago |
| MACD: Sell Signal | Oct 29, 2:50 PM | 4 days ago |
| SMA: Bearish | Oct 29, 2:45 PM | 4 days ago |
| RSI: Overbought | Oct 29, 2:20 PM | 4 days ago |
| MACD: Buy Signal | Oct 29, 2:10 PM | 4 days ago |
| SMA: Bullish | Oct 29, 2:00 PM | 4 days ago |
| SMA: Bearish | Oct 29, 1:50 PM | 4 days ago |
| SMA: Bullish | Oct 29, 12:55 PM | 4 days ago |
| SMA: Bearish | Oct 29, 12:35 PM | 4 days ago |
| MACD: Sell Signal | Oct 29, 12:00 PM | 4 days ago |
| SMA: Bullish | Oct 29, 11:55 AM | 4 days ago |
| SMA: Bearish | Oct 29, 11:50 AM | 4 days ago |
| SMA: Bullish | Oct 29, 9:50 AM | 4 days ago |
| SMA: Bullish | Oct 29, 9:50 AM | 4 days ago |
| SMA: Bearish | Oct 29, 9:40 AM | 4 days ago |
| SMA: Bearish | Oct 29, 9:40 AM | 4 days ago |
| SMA: Bullish | Oct 29, 9:30 AM | 4 days ago |
| SMA: Bullish | Oct 29, 9:30 AM | 4 days ago |
| MACD: Buy Signal | Oct 29, 9:30 AM | 4 days ago |
| SMA: Bearish | Oct 28, 3:55 PM | 5 days ago |
| MACD: Sell Signal | Oct 28, 3:55 PM | 5 days ago |
| SMA: Bullish | Oct 28, 3:45 PM | 5 days ago |
| MACD: Buy Signal | Oct 28, 3:45 PM | 5 days ago |
| SMA: Bearish | Oct 28, 3:40 PM | 5 days ago |
| SMA: Bullish | Oct 28, 3:35 PM | 5 days ago |
| MACD: Sell Signal | Oct 28, 3:10 PM | 5 days ago |
| SMA: Bearish | Oct 28, 2:55 PM | 5 days ago |
| SMA: Bullish | Oct 28, 2:35 PM | 5 days ago |
| SMA: Bullish | Oct 28, 2:25 PM | 5 days ago |
| SMA: Bearish | Oct 28, 2:20 PM | 5 days ago |
| MACD: Buy Signal | Oct 28, 2:15 PM | 5 days ago |
| SMA: Bullish | Oct 28, 2:05 PM | 5 days ago |
| SMA: Bearish | Oct 28, 1:35 PM | 5 days ago |
| SMA: Bullish | Oct 28, 1:10 PM | 5 days ago |
| SMA: Bearish | Oct 28, 12:00 PM | 5 days ago |
| SMA: Bearish | Oct 28, 12:00 PM | 5 days ago |
| SMA: Bullish | Oct 28, 11:55 AM | 5 days ago |
| SMA: Bearish | Oct 28, 11:40 AM | 5 days ago |
| SMA: Bullish | Oct 28, 11:35 AM | 5 days ago |
| SMA: Bearish | Oct 28, 11:20 AM | 5 days ago |
| SMA: Bullish | Oct 28, 11:15 AM | 5 days ago |
| SMA: Bearish | Oct 28, 11:10 AM | 5 days ago |
| MACD: Sell Signal | Oct 28, 11:10 AM | 5 days ago |
| SMA: Bullish | Oct 28, 10:45 AM | 5 days ago |
| SMA: Bearish | Oct 28, 10:40 AM | 5 days ago |
| SMA: Bullish | Oct 28, 10:35 AM | 5 days ago |
| SMA: Bearish | Oct 28, 10:20 AM | 5 days ago |
| RSI: Overbought | Oct 28, 10:10 AM | 5 days ago |
| RSI: Overbought | Oct 28, 9:55 AM | 5 days ago |
| RSI: Overbought | Oct 28, 9:40 AM | 5 days ago |
| SMA: Bullish | Oct 28, 9:30 AM | 5 days ago |
| SMA: Bullish | Oct 28, 9:30 AM | 5 days ago |
| MACD: Buy Signal | Oct 28, 9:30 AM | 5 days ago |
| SMA: Bearish | Oct 27, 2:55 PM | 6 days ago |
| SMA: Bullish | Oct 27, 2:45 PM | 6 days ago |
| SMA: Bearish | Oct 27, 2:15 PM | 6 days ago |
| SMA: Bearish | Oct 27, 2:15 PM | 6 days ago |
| SMA: Bullish | Oct 27, 2:10 PM | 6 days ago |
| SMA: Bullish | Oct 27, 2:00 PM | 6 days ago |
| SMA: Bearish | Oct 27, 1:20 PM | 6 days ago |
| SMA: Bullish | Oct 27, 12:45 PM | 6 days ago |
| SMA: Bearish | Oct 27, 12:40 PM | 6 days ago |
| SMA: Bullish | Oct 27, 12:35 PM | 6 days ago |
| SMA: Bearish | Oct 27, 12:30 PM | 6 days ago |
| SMA: Bullish | Oct 27, 12:15 PM | 6 days ago |
| SMA: Bearish | Oct 27, 12:10 PM | 6 days ago |
| SMA: Bullish | Oct 27, 12:05 PM | 6 days ago |
| SMA: Bearish | Oct 27, 12:00 PM | 6 days ago |
| SMA: Bullish | Oct 27, 11:55 AM | 6 days ago |
| SMA: Bearish | Oct 27, 11:20 AM | 6 days ago |
News
6 days ago prnewswire.com
Did GeneDx Holdings Corp. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be…
1 week ago benzinga.com
Range Resources, Xtend AI Robotics, Oruka Therapeutics And Other Big Stocks Moving Higher On Monday
U.S. stocks rose; Dow gained 350 points. Range Resources jumped 15% on EQT acquisition, while Surgery Partners and others posted sharp gains.
1 week ago benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Pomdoctor (NASDAQ:POM) shares rose 25.6% to $1.47 during Friday's after-market session. The market value of their outstanding shares is at $8.3 million. GeneDx Holdings (NASDAQ:WGS) shares…
1 week ago businesswire.com
GeneDx to Report Third Quarter 2026 Financial Results on Monday, November 9, 2026
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced it will release financial…
-
1 week ago benzinga.com
GeneDx Plans To Enhance Its Genome Testing Portfolio With Long-Read Whole Genome Sequencing
Long-read sequencing analyzes longer stretches of DNA to identify complex genetic variation, including certain structural variants and repeat expansions that can go undetected by traditional…
1 week ago businesswire.com
GeneDx Expands Diagnostic Leadership with Long-Read Genome Sequencing, Advancing Rare Disease Diagnosis
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced plans to enhance its genome…
2 weeks ago businesswire.com
GeneDx Advances Clinical Adoption of Genomic Medicine with 27 Abstracts at ASHG 2026
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx, the leader in rare disease diagnosis and improving health through the power of genomic data, today announced 27 accepted scientific abstracts at the…
2 weeks ago defenseworld.net
GeneDx (NASDAQ:WGS) Stock Falls 5.5% – Here’s What Happened
Shares of GeneDx Holdings Corp. (NASDAQ: WGS - Get Free Report) were down 5.5% during mid-day trading on Friday. The company traded as low as $66.92 and last traded at $66.3710. Approximately 32,972…
2 weeks ago defenseworld.net
Analyzing GeneDx (NASDAQ:WGS) and LifeMD (NASDAQ:LFMD)
LifeMD (NASDAQ: LFMD - Get Free Report) and GeneDx (NASDAQ: WGS - Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses…
3 weeks ago defenseworld.net
Comparing GeneDx (NASDAQ:WGS) & Brookdale Senior Living (NYSE:BKD)
Brookdale Senior Living (NYSE: BKD - Get Free Report) and GeneDx (NASDAQ: WGS - Get Free Report) are both mid-cap healthcare companies, but which is the superior stock? We will contrast the two…
3 weeks ago benzinga.com
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
3 weeks ago gurufocus.com
GeneDx Presents New Evidence Advancing Genomic Newborn Screening at ICoNS 2026
GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced new findings to be presented
-
3 weeks ago benzinga.com
GeneDx To Present New Results At International Consortium On Newborn Sequencing For Its Genomic Newborn Screening
GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced new findings to be presented at the International Consortium on…
3 weeks ago businesswire.com
GeneDx Presents New Evidence Advancing Genomic Newborn Screening at ICoNS 2026
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx Presents New Evidence Advancing Genomic Newborn Screening at ICoNS 2026.
4 weeks ago gurufocus.com
GeneDx Holdings Corp (WGS) Shares Surge 4.3% -- What GF Score of 67 Tells Investors
On October 05, 2026, GeneDx Holdings Corp (WGS) shares rose 4.3% to $76.27, reflecting a recovery from a recent decline. The stock has faced significant volatil
1 month ago businesswire.com
GeneDx Introduces Easy Order at AAP 2026 to Simplify Genomic Testing in Everyday Pediatric Care
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx introduces Easy Order at AAP 2026 to simplify genomic testing in everyday pediatric care.
-
1 month ago benzinga.com
Guggenheim Maintains Buy on GeneDx Holdings, Raises Price Target to $83
Guggenheim analyst Subbu Nambi maintains GeneDx Holdings (NASDAQ:WGS) with a Buy and raises the price target from $74 to $83.
1 month ago defenseworld.net
Kevin Feeley Sells 3,728 Shares of GeneDx (NASDAQ:WGS) Stock
GeneDx Holdings Corp. (NASDAQ: WGS - Get Free Report) CFO Kevin Feeley sold 3,728 shares of GeneDx stock in a transaction that occurred on Wednesday, September 16th. The shares were sold at an…
1 month ago gurufocus.com
Tempus Launches Effort to Build the Largest Multimodal Whole-Genome Dataset to Advance AI-Driven Healthcare Innovation
Tempus AI, Inc. (NASDAQ: TEM) today announced an initiative to build a research platform containing 100,000 whole genomes linked to longitudinal clinical inform
-
1 month ago benzinga.com
GeneDx Partners With Beren Therapeutics To Launch The NPC GenomeComplete Sponsored Testing Program For Niemann-Pick Disease Type C
The program provides no-cost comprehensive genome sequencing for eligible pediatric patients with clinical findings, family history, or biomarker evidence suggestive of Niemann-Pick Disease Type C…
1 month ago businesswire.com
GeneDx and Beren Therapeutics Launch NPC GenomeComplete to Improve Diagnosis of Niemann-Pick Disease Type C
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx and Beren Therapeutics Launch NPC GenomeComplete to Improve Diagnosis of Niemann-Pick Disease Type C.
1 month ago zacks.com
3 Promising Genomics Stocks in the Spotlight in 2026
Genomics is reshaping healthcare, with WGS, NEO and NTLA advancing diagnostics and precision medicine.
2 months ago businesswire.com
GeneDx CEO Katherine Stueland Recognized as a 2026 Fierce 50 Honoree
GAITHERSBURG, Md.--(BUSINESS WIRE)--Katherine Stueland, CEO of GeneDx, has been named a 2026 Fierce 50 honoree for Health Equity.
2 months ago gurufocus.com
GeneDx Holdings Corp (WGS) Shares Surge 3.3% -- What GF Score of 65 Tells Investors
On August 26, 2026, GeneDx Holdings Corp (WGS) shares rose 3.3%, bringing the current price to $90.28. The stock is trading within a 52-week range of $32.21 to
2 months ago benzinga.com
Short Sellers Are All-In on These 10 Stocks — Squeeze Watch List Inside
Bears have piled into a familiar batch of volatile, heavily bet-against names, and nowhere is the wager bigger than on Venture Global, Inc. (NYSE:VG). More than 80% of its float is sold short, the…
2 months ago benzinga.com
Short Sellers Are All-In on These 10 Stocks — Squeeze Watch List Inside
Ondas, SoundHound AI and CleanSpark are in the top ten most-heavily shorted stocks in the market right now.
2 months ago gurufocus.com
GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children's
[url="]GeneDx[/url] (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced new data publish
-
2 months ago benzinga.com
GeneDx Announces New Data Published In Genetics In Medicine Demonstrating First‑Tier Rapid Genome Sequencing Improves Diagnostic Rates, Patient Outcomes, And Operational Efficiency In Pediatric Care
Published in Genetics in Medicine, study shows broad inpatient implementation of rapid genome sequencing significantly increased diagnostic rates and reduced time to diagnosisChildren experiencing…
2 months ago businesswire.com
GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children's
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx and Seattle Children's show hospital-wide rapid genome sequencing accelerates accurate diagnosis and expands access to answers for children.
-
3 months ago benzinga.com
Canaccord Genuity Maintains Buy on GeneDx Holdings, Raises Price Target to $90
Canaccord Genuity analyst Kyle Mikson maintains GeneDx Holdings (NASDAQ:WGS) with a Buy and raises the price target from $75 to $90.
-
3 months ago benzinga.com
CORRECTION: GeneDx Hldgs Q2 Adj. EPS $0.01 Beats $(0.19) Estimate, Sales $114.440M Beat $111.011M Estimate
GeneDx Hldgs (NASDAQ:WGS) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.19) by 105.26 percent. This is a 98 percent decrease over earnings of $0.50…
-
3 months ago benzinga.com
GeneDx Holdings Affirms FY2026 Sales Guidance of $475.000M-$490.000M vs $478.367M Est
GeneDx Holdings (NASDAQ:WGS) affirms FY2026 sales outlook from $475.000 million-$490.000 million to $475.000 million-$490.000 million vs $478.367 million estimate.
-
4 months ago benzinga.com
Guggenheim Maintains Buy on GeneDx Holdings, Raises Price Target to $74
Guggenheim analyst Subbu Nambi maintains GeneDx Holdings (NASDAQ:WGS) with a Buy and raises the price target from $70 to $74.
-
4 months ago benzinga.com
Piper Sandler Maintains Overweight on GeneDx Holdings, Raises Price Target to $63
Piper Sandler analyst David Westenberg maintains GeneDx Holdings (NASDAQ:WGS) with a Overweight and raises the price target from $50 to $63.
-
5 months ago benzinga.com
10 Health Care Stocks Whale Activity In Today's Session
10 Health Care Stocks Whale Activity In Today's Session
5 months ago benzinga.com
10 Health Care Stocks With Whale Alerts In Today's Session
10 Health Care Stocks With Whale Alerts In Today's Session
5 months ago benzinga.com
Why Is GeneDx Stock Surging Thursday?
GeneDx (WGS) shares rebound 12% as bargain hunters move in following a steep post-earnings sell-off. Is the genetic testing leader oversold?
-
6 months ago benzinga.com
Canaccord Genuity Maintains Buy on GeneDx Holdings, Lowers Price Target to $75
Canaccord Genuity analyst Kyle Mikson maintains GeneDx Holdings (NASDAQ:WGS) with a Buy and lowers the price target from $100 to $75.
6 months ago benzinga.com
Crude Oil Down 4%; PayPal Shares Fall After Q1 Results
US stocks rise, Nasdaq gains 1%. Dow up 0.57%, Nasdaq up 1.03%, S&P 500 up 0.84%. Materials up 2.1%, financials down 0.2%. PayPal shares fall 9%.
-
6 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
12 Health Care Stocks Moving In Tuesday's Intraday Session
6 months ago benzinga.com
Dow Jumps Over 300 Points; Pfizer Posts Upbeat Earnings
US stocks rise, Dow gains 300 points. Materials jump 1.8%, real estate falls 0.2%. Pfizer's Q1 earnings beat expectations. Asian markets close lower.
-
6 months ago benzinga.com
Wells Fargo Maintains Overweight on GeneDx Holdings, Lowers Price Target to $75
Wells Fargo analyst Brandon Couillard maintains GeneDx Holdings (NASDAQ:WGS) with a Overweight and lowers the price target from $155 to $75.
-
6 months ago benzinga.com
Guggenheim Maintains Buy on GeneDx Holdings, Lowers Price Target to $70
Guggenheim analyst Subbu Nambi maintains GeneDx Holdings (NASDAQ:WGS) with a Buy and lowers the price target from $100 to $70.
6 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
6 months ago benzinga.com
GeneDx Holdings, Duolingo, Kosmos Energy And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Dow futures up 100 pts. Shares of GeneDx Holdings (WGS) down 39.2% after cutting FY26 sales guidance. Other stocks falling in pre-market trading.
-
6 months ago benzinga.com
BTIG Maintains Buy on GeneDx Holdings, Lowers Price Target to $90
BTIG analyst Mark Massaro maintains GeneDx Holdings (NASDAQ:WGS) with a Buy and lowers the price target from $170 to $90.
6 months ago benzinga.com
Why Sterling Infrastructure Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket
Shares of Sterling Infrastructure Inc (NASDAQ: STRL) jumped 22.5% in pre-market trading after reporting better-than-expected Q1 results and raising its FY26 guidance. Other gainers include BLZE,…
-
6 months ago benzinga.com
CORRECTION: GeneDx Hldgs Q1 Adj. EPS $(0.28) Misses $(0.01) Estimate, Sales $102.300M Miss $112.956M Estimate
GeneDx Hldgs (NASDAQ:WGS) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.01) by 2700 percent. This is a 203.7 percent decrease over earnings of…
-
6 months ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session
-
6 months ago benzinga.com
GeneDx Holdings Lowers FY2026 Sales Guidance from $540.000M-$555.000M to $475.000M-$490.000M vs $550.216M Est
GeneDx Holdings (NASDAQ:WGS) lowers FY2026 sales outlook from $540.000 million-$555.000 million to $475.000 million-$490.000 million vs $550.216 million estimate.